Difference in the risk profiles of carotid-femoral pulse wave velocity: results from two community-based studies in China and Sweden

被引:0
|
作者
Qian-Hui Guo
Iram Faqir Muhammad
Yan Borné
Chang-Sheng Sheng
Margaretha Persson
Ji-Guang Wang
Gunnar Engström
Yan Li
Peter M. Nilsson
机构
[1] Shanghai Jiaotong University School of Medicine,Centre for Epidemiological Studies and Clinical Trials and Centre for Vascular Evaluations, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital
[2] Skåne University Hospital,Department of Clinical Sciences, Lund University
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Carotid-femoral pulse wave velocity (cfPWV) and its risk factors may differ between various populations. Few studies have compared the risk profiles associated with cfPWV in different ethnic populations. The study population included 4321 subjects from Shanghai, China (n = 1272, age 75.0 ± 6.5 years, female 57.3%) and Malmö, Sweden (n = 3049, age 72.5 ± 5.5 years, female 60.4%). cfPWV was measured using the SphygmoCor device in both cohorts, with some difference in the determination of pulse transmission distance. The median cfPWV was 8.9 and 10.1 m/s (P < 0.001) respectively in the Chinese and Swedish subjects. cfPWV was associated (P < 0.05) with age, body mass index (BMI), mean arterial pressure (MAP), heart rate, fasting plasma glucose and serum triglycerides in both populations. The standardized effect size (m/s) associated with age (0.091 vs. 0.048, P < 0.001) and fasting plasma glucose (0.025 vs. 0.012, P = 0.046) was greater in the Swedish than Chinese subjects, whereas those with BMI (0.046 vs. 0.008, P < 0.001), MAP (0.079 vs. 0.067, P = 0.016), and heart rate (0.057 vs. 0.046, P = 0.036) were greater in Chinese. No difference was observed in those associated with serum triglycerides (P = 0.128). cfPWV was additionally associated with sex, serum total cholesterol, and on antihypertensive medication in the Swedish subjects, and with serum uric acid in the Chinese subjects (P ≤ 0.041). In conclusion, Chinese and Swedish subjects shared similar major risk factors of arterial stiffness, but with some differences in the strength of associations.
引用
收藏
页码:207 / 213
页数:6
相关论文
共 50 条
  • [11] OUTCOME-BASED THRESHOLD FOR CAROTID-FEMORAL PULSE WAVE VELOCITY: THE IDCARS STUDY
    An, Dewei
    Cheng, Yibang
    Huang, Qifang
    Li, Yan
    Staessen, Jan A.
    JOURNAL OF HYPERTENSION, 2023, 41 : E327 - E327
  • [12] OUTCOME-BASED THRESHOLD FOR CAROTID-FEMORAL PULSE WAVE VELOCITY: THE IDCARS STUDY
    An, Dewei
    Cheng, Yi-Bang
    Aparicio, Lucas S.
    Thijs, Lutgarde
    Huang, Qi-Fang
    Wei, Fang-Fei
    Barochiner, Jessica
    Sheng, Chang-Sheng
    Yang, Wen-Yi
    Niiranen, Teemu J.
    Boggia, Jose
    Stolarz-Skrzypek, Katarzyna
    Gilis-Malinowska, Natasza
    Tikhonoff, Valerie
    Wojciechowska, Wiktoria
    Casiglia, Edoardo
    Narkiewicz, Krzysztof
    Filipovsky, Jan
    Kawecka-Jaszcz, Kalina
    Wang, Ji-Guang
    Li, Yan
    Staessen, Jan A.
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E258 - E259
  • [13] Comparison of two instruments measuring carotid-femoral pulse wave velocity: Vicorder versus SphygmoCor
    van Leeuwen-Segarceanu, Elena M.
    Tromp, Wilma F.
    Bos, Willem-Jan W.
    Vogels, Oscar J. M.
    Groothoff, Jaap W.
    van der Lee, Johanna H.
    JOURNAL OF HYPERTENSION, 2010, 28 (08) : 1687 - 1691
  • [14] Comparative reproducibility of two generations of the Complior device estimating carotid-femoral pulse wave velocity
    Pereira, T. S.
    Madonado, J.
    Femandes, R.
    Simoes, D.
    Carpinteiro, H.
    Padrao, R.
    Resende, M.
    Santos, J.
    Carvalho, M.
    JOURNAL OF HYPERTENSION, 2008, 26 : S427 - S427
  • [15] Cuff-based assessment of carotid-femoral pulse wave velocity: comparison with the SphygmoCor device
    Woodcock-Smith, Jean
    Smith, Jane
    Miles, Karen
    McEniery, Carmel
    JOURNAL OF HUMAN HYPERTENSION, 2014, 28 (10) : 620 - 620
  • [16] Increased aortic stiffness in patients with fibromyalgia: results of a prospective study on carotid-femoral pulse wave velocity
    Triantafyllias, K.
    Stortz, M.
    de Blasi, M.
    Leistner, C.
    Weinmann-Menke, J.
    Schwarting, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (01) : S114 - S115
  • [17] Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
    Tougaard, Ninna Hahn
    Theilade, Simone
    Winther, Signe Abitz
    Tofte, Nete
    Ahluwalia, Tarunveer Singh
    Hansen, Tine Willum
    Rossing, Peter
    Frimodt-Moller, Marie
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (19):
  • [18] ASSOCIATION BETWEEN CARDIOVASCULAR RISK ESTIMATION BY THE ASCVD RISK ESTIMATOR AND CAROTID-FEMORAL PULSE WAVE VELOCITY IN OLDER INDIVIDUALS
    Ferreira-Filho, Sebastiao
    Souza, Denis
    Freitas, Ercilhana
    Peixoto, Aldo
    Araujo, Lucio
    JOURNAL OF HYPERTENSION, 2021, 39 : E167 - E167
  • [19] Validation of a cuff-based device for measuring carotid-femoral pulse wave velocity in children and adolescents
    Cai, Tommy Y.
    Meroni, Alice
    Dissanayake, Hasthi
    Phang, Melinda
    Avolio, Alberto
    Celermajer, David S.
    Butlin, Mark
    Skilton, Michael R.
    Qasem, Ahmad
    JOURNAL OF HUMAN HYPERTENSION, 2020, 34 (04) : 311 - 318
  • [20] Validation of a cuff-based device for measuring carotid-femoral pulse wave velocity in children and adolescents
    Tommy Y. Cai
    Alice Meroni
    Hasthi Dissanayake
    Melinda Phang
    Alberto Avolio
    David S. Celermajer
    Mark Butlin
    Michael R. Skilton
    Ahmad Qasem
    Journal of Human Hypertension, 2020, 34 : 311 - 318